CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience
-
Published:2024-09
Issue:
Volume:48
Page:100813
-
ISSN:2405-6308
-
Container-title:Clinical and Translational Radiation Oncology
-
language:en
-
Short-container-title:Clinical and Translational Radiation Oncology
Author:
Lee AlbertORCID,
Pasetsky Jared,
Lavrova ElizavetaORCID,
Wang Yi-Fang,
Sedor Geoffrey,
Li Feng L.,
Gallitto Matthew,
Garrett Matthew,
Elliston Carl,
Price Michael,
Kachnic Lisa A.,
Horowitz David P.ORCID
Reference15 articles.
1. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the dutch randomized phase III PREOPANC trial;Versteijne;J Clin Oncol,2020
2. Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: first results of the CONKO-007 trial;Fietkau;J Clin Oncol,2022
3. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial;Hammel;JAMA - J Am Med Assoc,2016
4. Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation;Krishnan;Int J Radiat Oncol Biol Phys,2016
5. Reyngold, M., Parikh, P., & Crane, C. H. (2019). Ablative radiation therapy for locally advanced pancreatic cancer: Techniques and results. In Radiation Oncology (Vol. 14, Issue 1). BioMed Central Ltd. https://doi.org/10.1186/s13014-019-1309-x.